TY - JOUR
T1 - Molecular Epidemiologic and Geo-Spatial Characterization of Staphylococcus aureus Cultured from Skin and Soft Tissue Infections from United States-Born and Immigrant Patients Living in New York City
AU - Immergluck, Lilly Cheng
AU - Lin, Xiting
AU - Geng, Ruijin
AU - Edelson, Mike
AU - Ali, Fatima
AU - Li, Chaohua
AU - Lin, T. J.
AU - Khalida, Chamanara
AU - Piper-Jenks, Nancy
AU - Pardos de la Gandara, Maria
AU - de Lencastre, Herminia
AU - Tomasz, Alexander
AU - Evering, Teresa H.
AU - Kost, Rhonda G.
AU - Vaughan, Roger
AU - Tobin, Jonathan N.
N1 - Funding Information:
The trial was funded by the Patient-Centered Outcomes Research Institute (PCORI) Contract Number CER-1402-10800 to Clinical Directors Network (Principal Investigator: Jonathan N. Tobin). PCORI scientific staff played no role in study design and conduct. The statements presented in this publication are solely the responsibility of the author(s) and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute® (PCORI®), its Board of Governors, or Methodology Committee. Additional research support was provided by pilot grants and an administrative supplement awarded to The Rockefeller University # UL1 TR001866 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program (Principal Investigator: Barry S. Coller) and research infrastructure was supported in part by a grant to Clinical Directors Network (CDN) “N2: Building a Network of Safety Net PBRNs” Grant # 1 P30-HS-021667—Center of Excellence (P30) for Practice-based Research and Learning, Agency for Healthcare Research and Quality (AHRQ) (Principal Investigator: Jonathan N. Tobin). Secondary data analyses and spatial analyses were funded in part from funds received from (PHS Grant UL1TR002378) from the Clinical and Translational Science Award Program, National Institutes of Health, as part of the Georgia Clinical and Translational Science Alliance (Georgia CTSA) (formerly, UL1RR025008, Atlanta Clinical and Translational Science Institute (ACTSI)) (Principal Investigators: Robert Taylor; Elizabeth Ofili; Andres’ Garcia and Bradley Phillips; Grant Number G12-RR03034, a component of the National Institutes of Health; Grant Number HS024338-01; K-08 Mentored Clinical Scientist Award, Agency for Healthcare Research & Quality (Principal Investigator: Lilly Cheng Immergluck); and Grant Number G08LM013190-0, National Library of Medicine (Principal Investigator: Lilly Cheng Immergluck).
Publisher Copyright:
© 2023 by the authors.
PY - 2023/10
Y1 - 2023/10
N2 - (1) Background: With increasing international travel and mass population displacement due to war, famine, climate change, and immigration, pathogens, such as Staphylococcus aureus (S. aureus), can also spread across borders. Methicillin-resistant S. aureus (MRSA) most commonly causes skin and soft tissue infections (SSTIs), as well as more invasive infections. One clonal strain, S. aureus USA300, originating in the United States, has spread worldwide. We hypothesized that S. aureus USA300 would still be the leading clonal strain among US-born compared to non-US-born residents, even though risk factors for SSTIs may be similar in these two populations (2) Methods: In this study, 421 participants presenting with SSTIs were enrolled from six community health centers (CHCs) in New York City. The prevalence, risk factors, and molecular characteristics for MRSA and specifically clonal strain USA300 were examined in relation to the patients’ self-identified country of birth. (3) Results: Patients born in the US were more likely to have S. aureus SSTIs identified as MRSA USA300. While being male and sharing hygiene products with others were also significant risks for MRSA SSTI, we found exposure to animals, such as owning a pet or working at an animal facility, was specifically associated with risk for SSTIs caused by MRSA USA300. Latin American USA300 variant (LV USA300) was most common in participants born in Latin America. Spatial analysis showed that MRSA USA300 SSTI cases were more clustered together compared to other clonal types either from MRSA or methicillin-sensitive S. aureus (MSSA) SSTI cases. (4) Conclusions: Immigrants with S. aureus infections have unique risk factors and S. aureus molecular characteristics that may differ from US-born patients. Hence, it is important to identify birthplace in MRSA surveillance and monitoring. Spatial analysis may also capture additional information for surveillance that other methods do not.
AB - (1) Background: With increasing international travel and mass population displacement due to war, famine, climate change, and immigration, pathogens, such as Staphylococcus aureus (S. aureus), can also spread across borders. Methicillin-resistant S. aureus (MRSA) most commonly causes skin and soft tissue infections (SSTIs), as well as more invasive infections. One clonal strain, S. aureus USA300, originating in the United States, has spread worldwide. We hypothesized that S. aureus USA300 would still be the leading clonal strain among US-born compared to non-US-born residents, even though risk factors for SSTIs may be similar in these two populations (2) Methods: In this study, 421 participants presenting with SSTIs were enrolled from six community health centers (CHCs) in New York City. The prevalence, risk factors, and molecular characteristics for MRSA and specifically clonal strain USA300 were examined in relation to the patients’ self-identified country of birth. (3) Results: Patients born in the US were more likely to have S. aureus SSTIs identified as MRSA USA300. While being male and sharing hygiene products with others were also significant risks for MRSA SSTI, we found exposure to animals, such as owning a pet or working at an animal facility, was specifically associated with risk for SSTIs caused by MRSA USA300. Latin American USA300 variant (LV USA300) was most common in participants born in Latin America. Spatial analysis showed that MRSA USA300 SSTI cases were more clustered together compared to other clonal types either from MRSA or methicillin-sensitive S. aureus (MSSA) SSTI cases. (4) Conclusions: Immigrants with S. aureus infections have unique risk factors and S. aureus molecular characteristics that may differ from US-born patients. Hence, it is important to identify birthplace in MRSA surveillance and monitoring. Spatial analysis may also capture additional information for surveillance that other methods do not.
KW - antibiotic resistance
KW - antimicrobial resistance
KW - Federally Qualified Health Centers (FQHCs)
KW - immigrant health
KW - methicillin-resistant Staphylococcus aureus (MRSA)
KW - methicillin-sensitive Staphylococcus aureus (MSSA)
KW - practice-based research networks (PBRNs)
KW - skin and soft tissue infections (SSTIs)
KW - staph aureus
UR - http://www.scopus.com/inward/record.url?scp=85175304640&partnerID=8YFLogxK
U2 - 10.3390/antibiotics12101541
DO - 10.3390/antibiotics12101541
M3 - Article
AN - SCOPUS:85175304640
SN - 2079-6382
VL - 12
JO - Antibiotics
JF - Antibiotics
IS - 10
M1 - 1541
ER -